Tumor scores at bowel and kidney were significantly less in the combination treatment group compared to the NCe-FA group alone, but they did not achieve significance compared to the cisplatinum group alone (Fig. 4d , f ).
← all excerpts
Folic acid tagged nanoceria as a novel therapeutic agent in ovarian cancer.
1
—
—